SCHEMBL23769389

SCHEMBL23769389

O=C(Nc1ccc2c(c1)OCC(=O)N2Cc1ccc[nH]c1=O)Nc1ccc2cc[nH]c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
ITGB3 P05106 4/20 0.39
ITGA2B P08514 4/20 0.39
ESR1 P03372 2/20 0.38
MAOA P21397 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
RORC P51449 1/20 0.36
PYGL P06737 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
CFTR P13569 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRB2 P47870 1/20 0.36
GABRA4 P48169 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29978269 0.89 TSHR (0.42) TSHRITGB3ITGA2BESR1MAOA
SCHEMBL23768999 0.89 TSHR (0.42) TSHRITGB3ITGA2BESR1MAOA
SCHEMBL29979073 0.88 ITGB3 (0.41) TSHRITGB3ITGA2BTDP1PYGL
SCHEMBL25138351 0.88 ITGB3 (0.41) TSHRITGB3ITGA2BTDP1PYGL
SCHEMBL29978527 0.87 ITGB3 (0.41) TSHRITGB3ITGA2BTDP1KDM4E
SCHEMBL29979346 0.87 ITGB3 (0.42) TSHRITGB3ITGA2BTDP1PYGL
SCHEMBL25138333 0.87 ITGB3 (0.41) TSHRITGB3ITGA2BTDP1KDM4E
SCHEMBL23769082 0.87 MAPT (0.38) TSHRITGB3ITGA2BESR1MAOA
SCHEMBL25138342 0.87 ITGB3 (0.42) TSHRITGB3ITGA2BTDP1PYGL
SCHEMBL29978911 0.87 MAPT (0.38) TSHRITGB3ITGA2BESR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151304-B Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2025-02-11 CN claimed
CN-115151304-A Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2022-10-04 CN claimed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed
WO-2021161230-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS STING1, CGAS, MAVS TSHR 1353/4885ITGB3 2071/4885ITGA2B 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.